Vinayak Bhat, PhD

Co-founder, President & COO, Elixir Medical

[Cardiology Today @CardiologyToday]

The first-time application of a triple-drug, site-specific antithrombotic therapy on a stent platform was safe and effective for managing thrombotic and bleeding risk after PCI #TCT2023 @TCTConference @CRFHeart #Cardiotwitter

Read more 👇
https://t.co/JGdoILrV1p

[Vinayak Bhat, PhD @vinayakdbhat]

@ChEnected @airproducts @SMitragotri @wyssinstitute Congratulations @SMitragotri, so very well deserved!

[Vinayak Bhat, PhD @vinayakdbhat]

@Drroxmehran @AmherstCollege @alexdangas1 Congratulations to Alex and the proud parents! @Drroxmehran

[Vinayak Bhat, PhD @vinayakdbhat]

Technology innovation of the uncaging DynamX and scientific rigor of the Bioadaptor RCT recognized at @PCRonline, thank you Dr Capodanno! @DFCapodanno.
@ElixirMed #bioadaptor

[Davide Capodanno @DFCapodanno]

I've been thinking a lot about what the three most significant trials could be for my practice among the many presented this year at #EuroPCR. In general, I prefer it when the primary endpoint is presented for the first time. This is my selection, feel free to disagree.

[Elixir Medical Corp @ElixirMed]

Packed house at both the #EuroPCR late-breaking session with Shigeru Saito, M.D., and our case-in-point symposium led by Antonio Colombo, M.D., on Wednesday! Learn more about our new data: https://t.co/ukInZdYDzo #CardioTwitter #Cardiology

*CE marked. Not approved in the U.S.

[Vinayak Bhat, PhD @vinayakdbhat]

@ElixirMed @PCRonline

[Vinayak Bhat, PhD @vinayakdbhat]

A team from Elixir will be at the EuroPCR to answer any questions about the latest innovation to treat your CAD patients after the release of the Late Breaking Clinical trial results from Bioadaptor Radomized clinical trial by Dr. Saito!

#bioadaptor #elixirmedical

[Vinayak Bhat, PhD @vinayakdbhat]

Please also join us for a fascinating case in point symposium discussion where a panel of world renowned experts share their experience with bioadaptor in treating their patients, including sharing long term imaging results!

[Elixir Medical Corp @ElixirMed]

Attending #EuroPCR 2023? Join us to learn more about the primary endpoint outcomes of the DynamX BIOADAPTOR RCT, comparing DynamX Bioadaptor to Resolute Onyx (n=445). https://t.co/XwJvDZ5RTq #CardioTwitter #medtech

*CE marked. Not approved in the US

[Vinayak Bhat, PhD @vinayakdbhat]

@Drroxmehran @IndianaUniv Such a well deserved and wonderful recognition! Congratulations!

[Elixir Medical Corp @ElixirMed]

Happy holidays from our team to yours! Thank you to all those committed to healing patients with heart and vascular disease.

PMN 1446 Rev A

[Vinayak Bhat, PhD @vinayakdbhat]

Outstanding tweetorial on PV loops!

[Alexander Hajduczok, MD 🇺🇦🙏 @AHajduczok]

Do you ❤️ hemodynamics? How about PV loops?

Here is Part I of our journey to to help YOU better understand PV loops and make them a little less daunting. Couldn't have done this without ⭐ @TJUHospital resident @jayamj94, and edits from @PSullivan000. Stay tuned for Part 2!

[Vinayak Bhat, PhD @vinayakdbhat]

Thank you Dr Hijazi @structuralheart for your support and guidance on @ElixirMed structural heart program #mitralrepair #annulusreduction

[Ziyad HIJAZI @structuralheart]

Just got back from SF after I used an innovative implant developed by Elixir Medical in a preclinical study to repair Mitral valve regurgitation with excellent results and reduction in mitral annulus area.

[Mladen Vidovich @mividovich]

About to present coronary rotation and stent "uncaging" data for the DynamX™ Coronary Bioadaptor System 👉🏻Pretty awesome new technology to address physiologic coronary motion @ElixirMed @TCTMD #TCT2022 @mmkansal - Emerging Clinical Science & Research Station 1

[Cardiology Today @CardiologyToday]

A novel drug-eluting coronary artery implant that “uncages” after 6 months may have similar performance to a DES while maintaining flexibility of the treated artery, according to an early study in humans @CRMjournal @mividovich @ChicagoVAMC #CardioTwitter https://t.co/Y48suq45X1

[Vinayak Bhat, PhD @vinayakdbhat]

One Heart, one Earth! Take good care of both💝

[Elixir Medical Corp @ElixirMed]

The Earth Day 2022 theme is “Invest In Our Planet.” Here are Earth Day events, activities, and what individuals and organizations can do to make a difference: https://t.co/T2Rl6D0Qz0 #investinourplanet

Image credit: saraillamas (Instagram)

[Vinayak Bhat, PhD @vinayakdbhat]

Thank you Dr Vidovich @mividovich for elegantly explaining the concept of coronary artery motion and the importance of uncaging the artery after PCI.

[Elixir Medical Corp @ElixirMed]

Dr. Mladen Vidovich (@mividovich) shares perspectives from his research on coronary artery motion:
- Why vessel rotation is important
- How stenting impacts it
- What vessels are impacted most
- Devices that best accommodate rotation

Watch this video: https://t.co/BFD3r0XkLh

[Vinayak Bhat, PhD @vinayakdbhat]

Thank you Prof Santoso and the team at Medistra Hospital! The innovative treatment with DynamX Bioadaptor now available for CAD patients in Indonesia.

[Elixir Medical Corp @ElixirMed]

Congratulations Prof. Teguh Santoso and team at RS Medistra Hospital in Jakarta, Indonesia, for completing the 1st DynamX case in the country!

For more information about bioadaptors: https://t.co/i7YDA8rEuw

*CE marked. Not approved in the USA

[Vinayak Bhat, PhD @vinayakdbhat]

Elixir is committed to generate extensive RCT data with the physiological adaptive DynamX Bioadaptor! An important milestone along the way!
#dynamx

[Elixir Medical Corp @ElixirMed]

We are thrilled to announce completion of enrollment in the BIOADAPTOR randomized controlled trial (RCT)!

Read press release: https://t.co/kFNPIktO6e

#DynamX #BeyondDES #CardioTwitter

[Vinayak Bhat, PhD @vinayakdbhat]

@ElixirMed @DocIanB @azsintjan Thank you Dr @DoclanB and team! Love the smiles in this picture!